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Objective: Warm blood cardioplegia requires interruption by ischemic 
intervals to aid visualization, We evaluated the safety of repeated interrup- 
tion of warm blood cardioplegia by normothermic ischemic periods of 
varying durations. Methods: In three groups of isolated cross-perfused 
canine hearts, left ventricular function was measured before and for 2 
hours of recovery after arrest, which comprised four 15-minute periods of 
cardioplegia alternating with three ischemic intervals of 15, 20, or 30 
minutes (Ils , I2o, and I3o). Metabolism was continuously measured by 
phosphorus 31-magnetic resonance spectroscopy. Results: Adenosine 
triphosphate levels fell progressively as ischemia was prolonged; after 
recovery, adenosine triph0sphate was 99% +- 6%, 90% +- 1% (p = 0.0004 vs 
control), and 68% - 3% (p = 0.0002) of control levels in Ils , I2o ~ and I3o , 
respectively. Intracellular acidosis with ischemia was most marked in Iao. 
After recovery, left ventricular maximal systolic elastance at constant heart 
rate and coronary perfusion pressure was maintained in I15 but fell to 85% 
--- 3% in Izo , (p = 0.003) and to 65% -- 6% (p = 0.003) of control values in 
Iao , while relaxation (tau) was prolonged only in Iao (p = 0.007). Conclu- 
sions: Hearts recover fully after three 15-minute periods of ischemia during 
warm blood cardioplegia, but deterioration, significant with 20-minute 
periods, is profound when the ischemic periods are lengthened to 30 
minutes. This suggests that in the clinical setting warm cardiop!egia can be 
safely interrupted for short intervals, but longer interruptions require 
caution. (J Thorac Cardiovasc Surg 1997;114:1070-80) 
W arm blood cardioplegia is accepted as a safe and efficacious method of myocardial protec- 
tion, 1-3 used by 10% of practicing cardiac surgeons 
From the Departments of Surgery, Cardiology, and Radiology, 
Massachusetts General Hospital and Harvard Medical 
School, Boston, Mass. 
This study was supported in part by grant HL12777 from the 
National Institutes of Health an d by generous gifts from Mr. 
Anthony A. Borgatti, Jr., Mr. and Mrs. Milton J. Silverman, 
and the Leon S. Newton Foundation. 
Received for publication Feb. 5, 1997; revisions requested May 
15, 1997; revisions received June 23, 1997; accepted for 
publication June 25, 1997. 
Address for reprints: W. M. Daggett, MD, Department of 
Surgery, Massachusetts General Hospital, BUL-119, Fruit St., 
Boston, MA 02114. 
Copyright © 1997 by Mosby-Year Book, Inc. 
0022-5223/97 $5.00 + 0 12/1/84445 
1070 
in the United States. 4 Since the first report of warm 
blood cardioplegia by Lichtenstein and coworkers, 5 
many clinical 6-8 and experimental 9-12 studies have 
described its advantages and disadvantages and have 
suggested refinements to the technique. 
Since continuous delivery of warm blood cardio- 
plegia may limit visualization during surgery, inter- 
mittent ischemic periods as long as 15 minutes have 
been used. 6' 13 The percentage of crossclamp time 
without cardioplegic infusion has been reported to 
be as high as 48.2% without apparent harm, pro- 
vided no single ischemic interval exceeds 13 min- 
utes. 14 Only a few experimental studies have ad- 
dressed the effects of ischemic intervals during warm 
blood cardioplegia, 15-1s 
To evaluate the safety of repeate d interruption of 
warm blood cardioplegia by normothermic schemic 
periods of varying durations, we studied isolated 
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cross-perfused isovolurnic anine hearts undergoing 
four 15-minute periods of cardioplegia lternating 
with three ischemic intervals of 15, 20, or 30 min- 
utes. The preparation allows measurement of  left 
ventricular (LV) function while its main hemody- 
namic determinants- -coronary perfusion pressure 
(CPP), LV volume, and heart rate- -are  controlled. 
Phosphorus 31-magnetic resonance spectroscopy 
(MRS) enabled repeated nondestructive measure- 
ments of myocardial metabolism. 
Methods 
Animal preparation. The preparation has been de- 
scribed in detail previouslyJ ° Dogs were tranquilized with 
acepromazine (0.4 mg/kg intramuscularly), anesthetized 
with intravenous chloralose (75 to 150 mg/kg) and ure- 
thane (0.75 to 15 gm/kg), intubated, and ventilated with 
oxygen-enriched air. A perfusion circuit was primed with 
500 ml of 6% hetastarch (Hespan, DuPont Pharma, 
Wilmington, Del.), 1000 ml of 0.9% saline solution, 50 
mEq of sodium bicarbonate, and 10,000 units of heparin. 
The heart of the donor dog (body weight 20.5 _+ 0.7 kg) 
was isolated without interrupting coronary perfusion and 
was cross-perfused ata constant CPP by a larger support 
dog, with a third animal used as the blood donor. After 
the chordae tendineae were transected, a large compliant 
balloon primed with saline solution was placed in the LV 
cavity of the isolated heart. The sinus node was crushed 
and the heart atrially paced at a constant rate of 150 
beats/rain. Copper electrodes were positioned in contact 
with the right ventricle and the posterolateral spect of 
the LV to allow defibrillation, if required. 
Coronary blood flow (CBF), CPP, support dog aortic 
pressure, and myocardial temperature measurement have 
been described. 1° LV pressure was measured by a high- 
fidelity micromanometer-tipped catheter (SPC 350 MR, 
Millar Instruments, Inc., Houston, Tex.) within the bal- 
loon and referenced to pressure measured through a 
fluid-filled catheter. 1° LV pressure, CPP, and aortic pres- 
sure were monitored and recorded on a strip chart and the 
LV pressure on magnetic tape. 
When its instrumentation was complete, the heart 
(maintained at 37 ° C) was supported by a pericardial sling 
within a water-jacketed acrylic cylinder (Plastic Design, 
Inc., Lexington, Mass.). The anterior LV surface was 
uppermost and positioned to maintain contact, without 
restricting cardiac pulsation, with an MRS surface coil 
mounted within the cylinder. The cylinder was placed in 
the center of a wide-bore horizontal magnetJ ° 
Heparin (6000 units) was administered to the Support 
dog for anticoagulation followed by 1000 units/hr. Indo- 
methacin 50 nig (INN: indometacin), methylprednisolone 
1 gm, chlorpheniramine maleate 10 mg (INN: chlorpheria- 
mine), and cimetidine (300 mg) intravenously were fol- 
lowed by a continuous infusion of 110 mg indomethacin, 1 
gm methylprednisolone, 600 mg cimetidine, and 20 nig 
chlorpheniramine maleate in 500 ml normal saline solu- 
tion at 50 ml/hr to maintain hemodynamic stability of the 
support dog. Hetastarch was infused if needed. Chloralose 
(2 mg/kg per minute) and urethane (20 mg/kg per 
minute), given intravenously, maintained anesthesia. Ven- 
tilation was adjusted and sodium bicarbonate added as 
necessary to maintain arterial oxygen tension above 200 
mm Hg and carbon dioxide tension and pH in the 
physiologic range. 
LV function. LV function curves at constant CPP and 
heart rate were obtained by stepwise increases in balloon 
volume to an LV end-diastolic pressure not exceeding 15 
mm Hg. At each LV volume, LV peak and end-diastolic 
pressures were recorded when heart rhythm and pressures 
were stable. LV systolic function was assessed from max- 
imal systolic elastance, the slope of a line fit by least- 
squares regression to the peak LV pressure-volume rela- 
tion. 19 LV end-diastolic pressure, as a measure of LV 
chamber stiffness, and the LV relaxation constant, tau 2° 
(averaged over 10 heart beats), were measured uring 
stability at constant LV volume and CPP. 1° 
Chemical measurements. Measurement ofblood gases, 
serum Na + and K +, and plasma ionized Ca 2+ has been 
described. 1°
MRS. Phosphorus 31 spectra were acquired in a 4.7- 
tesla GE-Omega MRS system (General Electric Co., 
Waterford, N.Y.) using a surface coil, as detailed previ- 
ouslyJ ° Before data acquisition, the field was shimmed to 
approximately 40 Hz (0.2 ppm) with the use of the 1H 
water signal. The radiofrequency pulse width was 40 msec. 
During the experiment, spectra were obtained continu- 
ously in approximately 1-minute blocks of 52 acquisitions 
using a pulse delay of 1 second and corrected to fully 
relaxed values with the use of data obtained at the 
beginning of each experiment with a pulse delay of 20 
seconds, lO
Data during cardioplegia or ischemia were summed 
over 1 minute and during control or reperfusion, over 10 
minutes. Inorganic phosphate peaks, evaluated by means 
of intensity, and other peaks, evaluated by means of area, 
were scaled to an intensity standard 1° and expressed as a 
percentage of their control values. Intracellular pH was 
calculated as previously described. 1° Bl-corrected areas 
were used to calculate the ratio of creatine phosphate 
(PCR) to adenosine triphosphate (ATP). When inorganic 
phosphate peaks were indistinguishable from noise-- 
generally the case during cardioplegia fter the third 
minute and during the first minute or two of ischemia-- 
inorganic phosphate was taken to be zero and intracellular 
pH could not be measured. When PCR was indistinguish- 
able from noise as in late ischemia, PCR was taken to be 
zero and intracellular pH was obtained from the chemical 
shift of the inorganic phosphate with respect to the 
standard. 
Experimental groups. All hearts received four 15- 
minute periods of warm blood cardioplegia (Cpl, Cp2, 
Cp3, and Cp4) alternating With three periods of normo- 
thermic ischemia (Iscl, Isc2, and Isc3) and were randomly 
assigned to one of three groups (Fig. 1): group 1, three 
15-minute periods of normothermic ischemia 015); group 
2, three 20-minute periods of normothermic ischemia 
020); and group 3, three 30-minute periods of normother- 
mic ischemia 03o)- 
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Fig. 1. Experimental groups (I15 , I2o and I3o ). After a control period (CTL), each group underwent arrest, 
comprising four 15-minute periods of warm blood cardioplegia lternating with three normothermic 
ischemic periods of 15, 20, or 30 minutes' duration, followed by 2 hours of recovery (RCV). Control and 
recovery periods are not to scale. Dark bars = 15 minutes of warm blood cardioplegia; open bars = ischemic 
periods, with duration in minutes indicated inside each bar. 
Protocol 
Controlperiod. CPP was maintained at 86 to 94 mm Hg 
and LV Volume adjusted until LV end-diastolic pressure 
was 8 to 10 mm Hg. When LV function was stable, Control 
MRS and hemodynamic data were acquired, and CBF was 
measured. Then LV function curves were obtained. 
Cardioplegia. LV volume was decreased until LV end- 
diastolic pressure declined to 0 to 5 mm Hg, and pacing 
was discontinued. Then blood from the arterial reservoir 
and a modified Fremes cardioplegic solution, 7 described 
later, were continuously mixed (4 parts blood to 1 part 
solution ) and delivered to the heart via the coronary 
perfusion line. Arrest was induced by infusing high- 
potassium blood cardioplegic solution at approximately 
100 ml/min for 5 minutes followed immediately by low- 
potassium blood cardioplegic solution. During Cpl, flow 
rate was adjusted if necessary to maintain CPP less than 
125 mm Hg. In the following cardioplegic periods, flow 
was adjusted to maintain CPP at 86 to 94 mm Hg, allowing 
reactive hyperemia. A hemofiltrator was used to minimize 
hemodilution caused by cardioplegia. 
Ischemia. After Cpl, Cp2, and Cp3, global ischemia 
was instituted for a duration appropriate to the experi- 
mental group. 
Recovery. After Cp4, addition of cardioplegic solution 
to coronary arterial blood was discontinued and recovery 
began. CPP was returned to 86 to 94 mm Hg. Electrical 
defibrillation was performed if necessary. Temporary 
atrioventricular block occurred in all hearts, necessitating 
temporary ventricular pacing. Atrial pacing was resumed 
as soon a s possible. After 30 minutes of recovery, the LV 
balloon was gradually inflated to the control LV volume. 
MRS and hemodynamic data were collected as during the 
control period at 60, 90, and 120 minutes of recovery. 
Finally, the LV was weighed. 
Cardioplegic solutions. Before admixture with blood, 
the solution contained the following components (in 
millimoles per liter) K +, 100 (high-potassium solution) or 
30 (low-potassium solution); Mg 2+, 9; Cff, 75; SO42-, 9; 
glucose, 278; citrate, 1.8; and citric acid, 0.3. After admix- 
ture with blood, K + was 22.8 -+ 1 mEq/L in the high- 
potassium solution; in the low-potassium solution, K + was 
12.8 _+ 0.3 mEq/L, ionized Ca 2+ 0.8 _+ 0.01 retool/L, Na + 
104 +_ 1.1 mEq/L, hematocrit 25.9% _+ 0.7%, pH 7.36 +- 
0.01, carbon dioxide tension 34.6 + 0.7 mm Hg, and 
oxygen tension 329 _+ 19 mm Hg. 
Calculations. Warm blood cardioplegia volume (ml/ 
100 gm LV) = crystalloid cardioplegia volume x 500/LV 
weight. 
Statistical analysis. Data underwent univariate repeat- 
ed-measures analysis of variance. Control data were con- 
trasted with subsequent measures by paired t test if the F 
statistic for time or the interaction between group and 
time was significant. The incidence of ventricular fibrilla- 
tion among the groups Was compared by Fisher's exact 
test. Continuous variables measured only once were com- 
pared by Student's t test. Values ofp < 0.05 were taken to 
indicate statistical significance. Data are expressed as 
mean + standard error of the mean. 
These studies were performed in accordance with insti- 
tutional guidelines and the "Guide for the Care and Use 
of Laboratory Animals" prepared by the Institute Of 
Laboratory Animal Resources and published by the Na- 
tional Institutes of Health (NIH Publication No. 85-23, 
revised 1985). 
Results 
Seven hearts were studied in each group. No 
functional or metabol ic  data during recovery were 
included for one heart  because of inabil ity to resume 
atrial pacing during recovery 015); for a second 
heart  these data were excluded because of the 
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Table I. Hemodynamic variables 
60 rain 90 rain 120 rain 
Group Control recovery recovery recovery 
AoP (mm Hg) Ii5 139 ± 3 133 ± 4 131 ± 4 134 _+ 4 
Ema x (mm Hg/ml) 
LVEDP (ram Hg) 
Tau (msec) 
CBF (mI/min/100 gm LV) 
I2o 133 --+ 5 122 + 6 124 ± 6 121 ± 6 
I3o 137 _+ 5 128 + 3 127 --+ 5 127 + 5 
I15 4.1 ± 0.5 4.4 ± 0.6 4.1 _+ 0.6* 4.4 ± 0.6 
I2o 4.4 _+ 0.4 3.7 + 0.4* 3.6 _+ 0.5? 3.7 ± 0.4* 
I3o 5.0 ± 0.3 3.0 -+ 0.3t 3.0 _+ 0.3t 3.3 + 0.4# 
I15 6.6 _+ 0.4 9.9 -+ 0.5# 7.6 _+ 0.4* 7.3 ± 0.5* 
I2o 6.7 _+ 0.3 9.3 2 1.0" 7.9 ± 1.0 7.6 _+ 0.8 
I3o 7.1 _+ 0.4 12.5 ± 0.3t 10.3 _+ 0.8? 9.7 _+ 0.9* 
115 47 _+ 1 48 ± 2 46 + 2 48 _+ 3 
I2o 47 + 2 51 -+ 3 47 ± 2 48 _+ 2 
I3o 43 + 2 72 + 7t  70 -+ 9* 68 +_ 8* 
I~5 47 _+ 5 58 + 4t  52 + 3t  55 _+ 6t  
I2o 53 _+ 9 68 + 17 60 + 13 56 _+ 10 
I3o 45 ± 4 58 + 9 52 ± 8 49 _+ 7 
Values are mean -+ standard error of the mean. AoP, Support dog aortic pressure; CBF, coronary blood flow; E,n,~ left ventricular maximal systolic elastance; 
LVEDP, left ventricular end-diastolic pressure; tau, left ventricular elaxation constant. 
*p = 0.0051 to 0.0500 versus control. 
tP = 0.0000 to 0.0050 versus control. 
Table I I .  High-energy phosphates and intracellular pH 
Group Control Cpl Iscl Cp2 Isc2 Cp3 Isc3 Cp4 2 hr Rcv 
% PCR I~5 100 108 -+ 3* 20 ± 2? 103 _+ 3 12 ± 2t  100 _+ 2 11 + 2t  97 _+ 3 100 ± 3 
I2o 100 105 --+ 3 8 --+ 2t  100 ± 2 6 --+ I t  98 ± 2 3 ± I t  98 --+ 3 109 ± 2t  
I~o 100 109 ± i t  1 --+ i t  107 ± I t  1 --+ 0.4t 112 ± 2) 2 ± 17 112 _+ 3* 115 --+ 4* 
% ATP I ls 100 96 ± 3 97 ± 4 96 ± 3 89 -+ 4* 94 ± 2* 91 -+ i t  90 ± 4* 99 ± 6 
I2o 100 94 -+ 5 97 -- 6 88 -+ 3* 86 ± 2t  81 ± 4t  79 -+ 2t  78 ± 3t  90 ± 1? 
I3o 100 102 _+ 5 87 ± 5 75 _+ 1# 71 + 4t  62 _+ 4t  58 -+ 5t  61 ± 5t  68 ± 3? 
PCR/ATP I15 2.0 ± 0.1 2.8 ± 0.1" 0.41 _+ 0.04t 2.2 _+ 0.1 0.27 ± 0.04t 2.1 _+ 0.1 0.25 ± 0.03t 2.2 + 0.l* 2.1 + 0.2 
I2o 2.0 _+ 0.2 2.2 ± 0.2 0.18 + 0.07t 2.3 ± 0.2* 0.13 ± 0.03t 2.4 _+ 0.2* 0.08 + 0.03t 2.5 ± 0.2t 2.4 + 0.2? 
I3o 1.9 _+ 0.1 2.1 ± 0.2 0.03 _+ 0.017 2.8 ± 0.2t 0.03 -+ 0.01t 3.7_+ OAt 0.06 + 0.03# 3.8 ± 0.5* 3.5 + 0.3t 
pH i I ls 7.04 _+ 0.05 - -  6.87 _+ 0.02* - -  6.82 -+ 0.02* - -  6.80 + 0.03# 7.02 2 0.06 
I2o 7.10 ± 0.07 - -  6.77 ± 0.01# - -  6.74 _+ 0.01# - -  6.68 ± 0.03? 7.00 - 0.06* 
I3o 7.05 ± 0.10 - -  6.46 ± 0.07* - -  6.53 -+ 0.06* - -  6.53 + 0.03* 7.05 + 0.07 
Values are mean _+ standard error of the mean. Cp/, Cp2, Cp3, and Cp4 indicate the ends of each cardioplegic period; Iscl, Isc2, and Isc3 indicate the ends 
of each ischemic period;pHi, intracellular pH; Rcv, the end of 2 hours of recovery; %PCR, percentage of control creatine phosphate; %ATP, percentage of 
control ATP; PCR/ATP, ratio of PCR to ATP. 
*p = 0.0051 to 0.0500 versus control. 
?p = 0.0000 to 0.0050 versus control. 
support dog's death (I20); data were obtained 
through only 1 hour of recovery in a third heart 
because of failure of a mechanical pump (130). LV 
weight was 105 + 5 gm and LV volume (corrected 
for balloon displacement volume) at which function 
was evaluated was 22.4 _+ 1.3 ml (no significant 
differences among groups). There was no significant 
difference between groups in hemodynamic or met- 
abolic variables before arrest (Tables I and II). At 
the control measurement, coronary arterial hemat- 
ocrit value was 35.1% + 0.7%, and plasma ionized 
calcium 1.18 _+ 0.01 mmol/L (no significant differ- 
ences among groups); neither changed significantly 
from these values during recovery. 
Cardioplegie arrest. Volume of high-potassium 
blood cardioplegic solution for induction was 477 + 
38 ml/100 gm LV (no significant differences among 
groups). Volumes of low-potassium blood car- 
dioplegic solution were 4130 _+ 500, 3970 + 590, and 
6200 _+ 1020 ml/100 gm LV in Ils , I2o, and I3o , 
respectively (no significant differences). Greater re- 
active hyperemia caused the higher volumes in I3o. 
High-energy phosphate metabolism. ATP and 
PCR during arrest are represented in Fig. 2; values 
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Fig. 2. The effect of periods of normothermic ischemia in the isolated cross-perfused canine heart during 
arrest by warm blood cardioplegia on PCR and ATP. Cpl, Cp2, Cp3, and Cp4 indicate successive 
cardioplegic periods; Iscl, Isc2, and Isc3 indicate successive ischemic periods. ATP is shown byfilled circles 
and PCR by open circles. Control levels of ATP and PCR (100%) are indicated by horizontal dotted lines. 
In the top panel, hearts were subjected to four 15-minute cardioplegic periods alternating with three 
15-minute ischemic periods (I19. In the middle panel, ischemic periods were extended to 20 minutes (I2o) 
and in the lower panel, to 30 minutes (I3o). Data are means + standard error of the mean. For clarity, 
standard errors of the mean are shown for only the first two data points in each period. 
and statistics for ATP, PCR and PCR/ATP are in 
Table II. The PCR/ATP ratio before arrest did not 
differ among groups. During Cpl, PCR increased 
slightly--significant in 115 and I30. In all groups, 
PCR decreased immediately during ischemia and 
rapidly fell to low levels before recovering com- 
pletely during the cardioplegic periods (Fig. 2). In 
the first ischemic period, PCR fell to significantly 
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lower levels as the duration of ischemia was pro- 
longed--to 20% of control in I15, 8% in I2o , and 1% 
in I30 (Table II). There were further declines with 
repeated ischemic periods; at the end of Isc3, PCR 
was 11% in I15, significantly above the PCR of 3% in 
I20 and 2% in I30. During Cp2, Cp3, and Cp4, PCR 
returned to the control level in I15 and I20 but rose 
most rapidly and to a significantly higher level in I30. 
PCR during recovery was at control levels in Ils 
(100%) but significantly elevated in I20 (109%) and 
I3o (115%). 
ATP declined during arrest in all groups, but 
more severely as the duration of the ischemic peri- 
ods increased (Fig. 2). During Iscl, ATP was at 97% 
of control in I15 and I20 but had fallen to 87% in I30 
(no significant differences vs control). By the end of 
CP2, ATP was significantly less than its control value 
in I20 and I30 but not in Ils. By the end of Isc2, ATP 
was significantly below control in all groups and 
remained so through the end of arrest, when ATP 
was 90% of control in I15, 78% in I20, and 61% in I30 
(Table II). 
In I30 during Iscl and Isc2, ATP was maintained 
until PCR fell to a very low level, approximately 5% 
of its control level, and then declined (Fig. 2). The 
declines continued into the following cardioplegic 
periods with ATP falling while PCR was increasing 
at least to its control level. Little or no decline was 
observed in ATP during Isc3 although PCR fell to 
2%. During recovery, ATP recovered to control 
levels in Ils (99%), was slightly depressed in I20 
(90%), and was substantially depressed in I30 (68%) 
(Table II). 
Inorganic phosphate and intracellular pH. Intra- 
cellular pH during arrest is depicted in Fig. 3; 
statistics for intracellular pH are presented in Table 
II. Control inorganic phosphate peaks were small, 
and in most hearts the increase of PCR during 
cardioplegia was accompanied by a decline in inor- 
ganic phosphate until it was indistinguishable from 
background noise. Intracellular pH increased by 
approximately 0.1 unit during the first 3 to 5 minutes 
of the ischemic periods and then decreased progres- 
sively (Fig. 3). Intracellular pH was lower at the end 
of all ischemie periods in I20 than in Ils, and in I30 
than in I20. During recovery, intracellular pH recov- 
ered to control values in I15 and I30 but was slightly 
below control in I20. During ischemia, inorganic 
phosphate increased ninefold to twelvefold as PCR 
declined. During recovery, inorganic phosphate re- 
turned to slightly above control values (141% _+ 
15%, 131% + 19%, and 163% _+ 25% in I15, I20 , and 
I30 , respectively). 
Recovery. Ventricular fibrillation occurred in five 
of seven hearts in I30, but in none of seven in I20 or 
I15 CO = 0.02, I20 or I15 vs I30)- Transient atrioven- 
tricular block occurred in all hearts. Aortic pressure 
during recovery was slightly but not significantly 
below control values (Table I). 
Ventricular performance (Table I and Fig. 4). 
Maximal systolic elastance was essentially stable 
throughout recovery in all groups. In I15, there was 
no evidence of deterioration of LV systolic perfor- 
mance from control levels. At 2 hours of recovery, 
percent maximal systolic elastance was 85% _+ 2.8% 
of control in I2o and 65% + 6.3% in I30. Throughout 
recovery, tau remained at control levels in I15 and 
I20, but was considerably prolonged in I30. LV 
end-diastolic pressure was increased substantially at 
1 hour of recovery in all groups, but most in I30 
(Table I). By 2 hours there was some improvement, 
with LV end-diastolic pressure slightly above con- 
trol in I15, insignificantly increased in I20 , but still 
markedly raised in I3o. Increases in LV end-diastolic 
pressure did not parallel increases in CBF. 
Discussion 
Electromechanical rrest of the working heart 
reduces myocardial oxygen consumption by 90%. 21 
However, oxygen delivery adequate for the reduced 
requirements during warm blood cardioplegia re- 
mains critical to prevent ischemic damage. The fact 
that warm blood cardioplegia is often interrupted 
during coronary artery surgery threatens the physi- 
ologic premise of the method, which is said to be 
aerobic myocardial protection. 6'v 
The use of intermittent periods of normothermic 
ischemia as long as 15 minutes during warm blood 
cardioplegia was reported by Lichtenstein and co- 
workers 6 in the original description of the tech- 
nique. Recent clinical trials 1' 3, s, 14 report interrup- 
tion of cardioplegia flow with good results. Our 
experimental data showed that four 15-minute peri- 
ods of warm blood cardioplegia alternating with 
three 15-minute periods of normothermic ischemia 
do not cause measurable deterioration in systolic 
function and metabolic recovery in the uncompro- 
raised canine heart. However, a slight but significant 
increase in LV stiffness was observed (Table I). An 
increase in the duration of the ischemic periods to 
20 minutes caused deterioration of function (Fig. 3) 
and a decrease in ATP that persisted to the end of 
recovery (Table II). With 30-minute periods of 
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Fig. 3. The effect of normothermic periods of ischemia during warm blood cardioplegia n intracellular pH 
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ischemia, function and ATP were profoundly de- 
pressed. 
Other experimental studies of normothermic isch- 
emic periods during warm blood cardioplegia 15-18 
have come to contradictory conclusions. Much of 
the observed variation in the protective ffect can be 
attributed to one of three variables: (1) length of the 
ischemic interval, (2) duration of cardioplegic rein- 
fusion between ischemic intervals, and (3) adequacy 
of cardioplegic distribution. For example, Ko and 
associates 15reported that intermittent warm blood 
cardioplegia, administered antegradely every 10 
minutes during 30 minutes of normothermic arrest 
in a canine model, produced greater tissue acidosis 
and functional deterioration than cardioplegia given 
every 5 minutes. This implies a significantly shorter 
"grace period" than in our study. Of note, the 
volume of cardioplegic solution delivered during 
each infusion was 350 ml. On the basis of the 
reactive hyperemia observed in our study, this infu- 
sion would take only 2 to 3 minutes to infuse, 
meaning that 70% to 80% of the crossclamp time 
was ischemic in the 10-minute group, well beyond 
the percentage used clinically. In Ko's study, there- 
fore, the cardioplegic reinfusion was probably too 
brief to be of optimal effect. 
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In contrast, Landymore, Marble, and Fris 16 found 
satisfactory myocardial preservation with antegrade 
warm blood cardioplegia dministered every 15 
minutes during 90 minutes of normothermic arrest 
in the dog, apparently a more severe protocol than 
Ko's. The volume of cardioplegic solution delivered 
with each infusion in this study was only 200 to 250 
ml, which again would have meant about 80% of the 
crossclamp time was ischemic. In both of these 
studies, 1s'16 normothermic ischemia was inter- 
rupted by brief infusions of warm blood cardioplegic 
solution while nearly all of the period of arrest was 
ischemic. Conceptually, this is quite different from 
the clinical use of warm blood cardioplegia, inwhich 
continuous infusion of cardioplegic solution is inter- 
rupted by brief intervals of ischemia. In our study, 
all hearts received four 15-minute periods of warm 
blood cardioplegia, with total ischemic times during 
normothermic arrest of 43%, 50%, and 60% of the 
total crossclamp time in I15, I20 and 130, respectively. 
Tian and coworkers i subjected isovolumic Lan- 
gendorff-perfused swine hearts (evaluated by MRS) 
to 90 minutes' arrest with antegrade warm blood 
cardioplegia interrupted by six 10-minute ischemic 
periods. The total ischemic time was 67% of the 
arrest period. ATP declined slightly during arrest 
but recovered fully. With each ischemic episode, 
intracellular pH fell by an average of 0.12 unit 
without evidence of the initial alkalinization that we 
observed (Fig. 3), and PCR fell to approximately 
50% of baseline. After a similar ischemic time we 
found that intracellular pH fell by 0.07 _+ 0.04 unit 
and PCR to 36% __+ 2% of baseline (in the first 
ischemic period of all groups from the scan at an 
average of 10.1 minutes of ischemia). In Tian's 
study] 8PCR and intracellular pH changes were not 
cumulative with repeated ischemic intervals. During 
the 30-minute recovery period, function evaluated 
by rate of pressure rise and rate-pressure product 
was equal to that after continuous warm blood 
cardioplegia. 
Even very brief ischemic periods may be damag- 
ing with a background of preexisting ischemia or 
with inadequate cardioplegic distribution. Matsuura 
and colleagues 17evaluated warm blood cardioplegia 
in a swine model of acute surgical revascularization 
to relieve regional ischemia imposed 90 minutes 
before cardiopiegic arrest. Retrograde warm blood 
cardioplegia during 45 minutes of arrest, interrupted 
by three 7-minute periods of normothermic sch- 
emia, increased tissue acidosis at the end of arrest 
and decreased echocardiographic wall motion 
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Fig. 4. The effect of normothermic periods of ischemia 
during warm blood cardioplegia onLV function at 2 hours 
of recovery. Statistics are in Table I. Em,~, Maximal LV 
systolic elastance; tau, LV relaxation constant; these vari- 
ables are expressed as a percentage of their respective 
control values. LVEDP, LV end-diastolic pressure; 
ALVEDP = (LV end-diastolic pressure at 2 hours of 
recovery) - (control LV end-diastolic pressure). Bars 
indicate standard error of the mean. 
scores during recovery when compared with inter- 
mittent antegrade/retrograde coldblood cardiople- 
gia or continuous retrograde warm blood cardiople- 
gia. In another study of the swine heart evaluated by 
MRS, Hoffenberg and colleagues 22 showed that 
retrograde continuous warm blood cardioplegi a re- 
sulted in metabolic hanges characteristic of isch- 
emia, which was attributed to the inhomogeneous 
distribution of retrograde cardioplegia. 23 In Mat- 
suura's tudy, 17 inadequate protection afforded by 
warm retrograde cardioplegia compounded by pre- 
existing regional ischemia may account for the dam- 
aging effect of interrupting cardioplegic flow by 
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ischemic periods as short as 7 minutes. There was no 
MRS evidence of unintentional ischemia during 
antegrade delivery of cardioplegic solution in our 
model or in Tian's. t8 
We observed an initial increase of intracellular 
pH during ischemia to which the creatine kinase 
reaction may contribute24: 
PCR + ADP + H + --> ATP + creatine 
Ischemia prevents the aerobic production of ATP, but 
initially ATP is replenished by the creatine kinase 
reaction as fast as it is consumed. PCR hydrolysis takes 
up hydrogen ions (H ÷) whereas ATP hydrolysis pro- 
duces them. Glycolytic formation and subsequent hy- 
drolysis of ATP together are a net source of H + 
production. 24In our study, the balance of H ÷ produc- 
tion and consumption resulted in an overall decrease 
in [H ÷] in the first few minutes of ischemia while ATP 
remained more or less steady (Figs. 2 and 3). Compa- 
rable initial transient alkalinization has been observed 
by othersY In our study, as ischemia progressed, PCR 
reached very low levels, and ATP hydrolysis predom- 
inated with progressive acidosis. Other reactions that 
release or take up H + may have contributed to the 
H ÷ balance. 24 Anaerobic glycolysis as a source of ATP 
during ischemia is inadequate and may be transient24; 
it is inhibited by acidosis and the lack of oxidized 
nicotinamide-adenine dinucleotide (NAD+). 26 
In I30 in the first tWo ischemic periods, ATP stores 
began to fall sharply only when PCR declined to 5% 
to 10% of its control level at about 20 minutes of 
ischemia (Fig. 2). The declines in ATP in i30 con- 
tinued through the initial minutes of cardioplegic 
reperfusion, as reported by others, 27 whereas PCR 
recovered (Fig. 2). In the third ischemic period, any 
additional fall in ATP was minimal. During the 
cardioplegic periods after ischemia, PCR recovered 
to control evels in I15 and I20 but exceeded control 
in I30. The postisChemic PCR overshoot, 28and the 
continued ATP decline during cardioplegic reperfu- 
sion, 27 may be markers of severe injury. A low 
intracellular pH during arrest here and a low tissue 
pH in a prior study 29 both predicted poor recovery. 
The isolated heart preparation has limitations, 
discussed previously. 1°Coronary perfusion was un- 
interrupted uring the surgical preparation to avoid 
preconditioning. We maintained support dog aortic 
pressure within physiologic limits to avoid effects on 
contractility of the isolated heart resulting from 
humoral influences arising in the support dog. Ion- 
ized calcium, also an influence on contractility, was 
at the control level during recovery. Hemodilution, 
which increases CBF, was avoided. Increases in LV 
end-diastolic pressure during recovery did not par- 
allel and cannot be attributed to the modest in- 
creases in CBF (Table i). In the absence of a 
collateral circulation, decreased washout of car- 
dioplegic solution could be protective, but de- 
creased washout of metabolites during ischemia 
could be deleterious. In the clinical setting, the 
presence of coronary artery disease may cause un- 
intentional ischemia through maldistribution during 
antegrade delivery. In our model, antegrade delivery 
was used in an optimal manner with uninjured 
myocardium, which could be a factor in the level of 
recovery we found. 
In conclusion, in this study of the uncompromised 
canine heart, the safe interval of normothermic 
ischemia during antegrade warm blood cardioplegia 
appears to be in the 15-minute range, but these 
results should not be extrapolated to the clinical 
setting, where injured myocardium or maldistribu- 
tion of cardioplegic solution may make the margin 
finer. Our results and those of others 18 suggest hat 
warm blood cardioplegia can be safely interrupted 
for short periods of time. Longer periods of normo- 
thermic ischemia require caution. 
We thank Linda Dell'Olio and Anne Manning for 
manuscript preparation and Jennifer Akins for technical 
assistance. 
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Commentary 
Dr. Carias de Oliveira and colleagues performed an 
elegant evaluation of intermittent warm blood cardiople- 
gia and found that 15 minutes of cardioplegic nterruption 
with 15 minutes of reperfusion was well tolerated by the 
normal canine heart. They also found that 30 minutes of 
cardioplegic nterruption with 15 minutes of reperfusion 
resulted in substantial metabolic and functional deterio- 
ration that persisted at least 2 hours after cardioplegic 
arrest. They recommend that cardiac surgeons hould 
limit warm cardioplegic interruptions, particularly in pa- 
tients with poor preoperative l ft ventricular function, 
preoperative ischemia, or left ventricular hypertrophy. 
This is an excellent study, which deserves careful con- 
sideration by cardiac surgeons interested inwarm cardio- 
plegia. The authors used magnetic resonance spectros- 
copy (MRS) to assess myocardial pH and high-energy 
phosphates during intermittent warm cardioplegia nd 
reperfusion. MRS is a revolutionary assessment tool that 
allows noninvasive quantification of tissue metabolites in
vivo.I However, a number of cautions must be exercised in 
the interpretation f the results of this study. The authors 
used blood-perfused isolated canine hearts. The tolerance 
of normal canine myocardium to interrupted cardioplegia 
may differ, as the authors suggest, from that of a heart 
with coronary disease and preoperative ischemia. In this 
study, an intraventricular balloon was used to assess 
ventricular function. The authors found a significant in- 
crease in left ventricular end-diastolic pressure and a 
decrease in diastolic function after cardioplegic nterrup- 
tions of 20 or 30 minutes, This alteration in diastolic 
compliance renders the assessment of systolic function 
difficult. They found a decrease in end-systolic elastance 
after 30 minutes of cardioplegic interruption. Maximal 
elastance was not measured. A better measure of cardiac 
function would have been preload recruitable stroke 
work, which could have been calculated from pressure- 
volume loops. Unfortunately, the authors did not assess 
this measure of cardiac function. 
Their evaluation of cardiac high-energy phosphates and 
myocardial cidosis provides clear evidence of progressive 
ischemia during cardioplegic nterruptions. These results 
suggest cardiac surgeons hould limit warm cardioplegic 
interruptions to less than 30 minutes. Altering the method 
of delivering cardioplegic solutions may decrease car- 
dioplegic interruption times. In our experience, optimal 
visualization of distal anastomoses required interruption 
of warm antegrade cardioplegia for 10 to 20 minutes in 
90% of patients, corresponding to 42% of the crossclamp 
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period) The use of warm retrograde blood cardioplegia, in
Contrast, decreased cardioplegic nterruptions toonly 27% of 
the duration of crossclamping. This does not necessarily 
mean, however, that retrograde cardioplegia results in less 
ischemia. Retrograde cardioplegia may decrease cardiople- 
gic interruption time simply by decreasing tissue perfusion, 
which in turn leads to decreased effluent from coronary 
arteriotomies and improved visualization of the anastomosis. 
Indeed, retrograde cardioplegia results in increased levels of 
inorganic phosphate and decreased levels of creatine phos- 
phate compared with antegrade cardioplegia. 3 Using a com- 
bination of antegrade and retrograde cardioplegia (i.e., simul- 
taneous cardioplegia administration retrograde through the 
coronary sinus and antegrade through saphenous vein grafts) 
may be the optimal method of reducing the duration of 
cardioplegic nterruption without significantly impairing vis- 
ibility. 4 In addition, lowering the temperature of the car- 
dioplegic solution from 37 ° C to 29 ° C ("tepid" cardioplegia) 
may reduce myocardial oxygen requirements and improve 
the preservation of myocardial metabolism and ventricular 
function. 4 These Strategies may minimize the deleterious 
effects of cardioplegic nterruption during cardiac surgery. 
We have used arterial and coronary Sinus serum samples 
to evaluate myocardial metabolism during cardioplegic de- 
livery. We measured lactate production after resumption of 
antegrade or retrograde cardioplegia fter interruptions of 
up to 15 minutes (unpublished ata). Interruption of ante- 
grade warm blood cardioplegia results in moderate lactate 
washout with resumption of cardioplegia; the magnitude of 
this lactate production is not related to the duration of 
cardioplegic nterruption. In contrast, interruption of retro- 
grade warm blood cardioplegia results in greater lactate 
production at all times, compared with antegrade cardiople- 
gia, and lactate production and oxygen consumption i crease 
significantly after only 7 minutes (implying washout of lac- 
tate accumulated during anaerobic metabolism, and repay- 
ment of an oxygen debt). 
In addition to metabolic measurements, we have also 
assessed clinical outcomes during warm blood cardiople- 
gia. A randomized clinical trial comparing normothermic 
and hypothermic blood cardioplegia was performed in 
1732 patients at the University of Toronto. 5 It demon- 
strated a significant reduction in the incidence of low 
cardiac output syndrome and perioperative nzymatic 
myocardial infarction in patients randomized to warm 
blood cardioplegia. The effects of cardioplegic interrup- 
tion was subsequently assessed post hoc in 720 patients 
derived from the warm treatment arm. 6 Intermittency was 
analyzed as cumulative ischemic time as a percentage of 
total crossclamp time, or as the single longest ischemic 
interval. Longest ischemic time (highest quartile > 13 
minutes) was an important predictor of adverse cardiac 
outcomes (mortality, myocardial infarction, or low output 
syndrome, p = 0.053), but no consistent relationship was 
identified for cumulative ischemic time. We concluded 
that repeated interruptions of warm blood cardioplegia 
followed by sufficient cardioplegic reinfusion is a safe 
method of myocardial protection provided single inter- 
ruptions ar e 13 minutes or less. Dr. Carias de Oliveira and 
colleagues used a model of ischemia with 15 minutes of 
reperfusion between each ischemic episode. Although the 
length Of interruptions i compatible with clinical practice 
(average longest ischemic interval 11.4 -+ 4.0 mimites for 
732 patients from the Warm Heart Trial), 6 15 minutes of 
reperfusion may represent an ideal rather than reflect 
routine practice. Additional studies testing shorter peri- 
ods of reperfusion would provide valuable information 
that may more closely mimic typical surgeon behavior. It 
would appear from closer inspection of the first panel of 
Fig. 2, in conjunction with other animal data, 7that shorter 
periods of reperfusion would also be acceptable. 
In summary, this is a well-designed study assessing the 
effects of warm intermittent blood cardioplegia. The 
results uggest that 15 minutes of repeated warm ischemia 
is safe, but that cardioplegic interruptions of 30 minutes 
are probably harmful. This length of time is clinically 
feasible in the majority of coronary bypass operations, 
particularly if combinations of antegrade and retrograde 
cardloplegia re used. Our myocardial metabolic and 
clinical data would also suggest hat this length of warm 
ischemic time is well tolerated in coronary bypass urgery. 
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